[
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 12:29 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 12:29 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 12:29 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 12:29 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T04:31:04+00:00",
    "headline": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
    "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
    "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
      "content": {
        "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
        "contentType": "STORY",
        "title": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
        "description": "",
        "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
        "pubDate": "2025-11-05T04:31:04Z",
        "displayTime": "2025-11-05T04:31:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce",
          "originalWidth": 720,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TTciiphdQR88uNeAEBOPyA--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 720,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pQuyOpoLC5jVJ3Eq2VY_ZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "https://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "SLM"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "EL"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "MELI"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "HAL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "MOH"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "IDLE-USD"
            },
            {
              "symbol": "OPAI.PVT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T00:37:20+00:00",
    "headline": "Pfizer (PFE) Profit Margins Double—Challenges Bearish View Despite $4.7B Loss and Revenue Headwinds",
    "summary": "Pfizer (PFE) posted notable earnings growth, with net profit margins improving to 15.6%, a lift from the previous period’s 7%. Year-over-year, EPS growth soared 133.3%, marking a sharp reversal from the company’s five-year average decline of 13.2% per year, even as a significant one-off loss of $4.7 billion weighed on the latest results. Looking ahead, investors are weighing the company’s stronger margins and attractive valuation multiples against forecasts for a 3.2% annual decline in...",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "236bf18b-c086-3c32-82b7-502c6d20133d",
      "content": {
        "id": "236bf18b-c086-3c32-82b7-502c6d20133d",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Profit Margins Double—Challenges Bearish View Despite $4.7B Loss and Revenue Headwinds",
        "description": "",
        "summary": "Pfizer (PFE) posted notable earnings growth, with net profit margins improving to 15.6%, a lift from the previous period’s 7%. Year-over-year, EPS growth soared 133.3%, marking a sharp reversal from the company’s five-year average decline of 13.2% per year, even as a significant one-off loss of $4.7 billion weighed on the latest results. Looking ahead, investors are weighing the company’s stronger margins and attractive valuation multiples against forecasts for a 3.2% annual decline in...",
        "pubDate": "2025-11-05T00:37:20Z",
        "displayTime": "2025-11-05T00:37:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:32:25+00:00",
    "headline": "PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2d150d0b-ad11-37ce-b0c3-dc67664e8eec",
      "content": {
        "id": "2d150d0b-ad11-37ce-b0c3-dc67664e8eec",
        "contentType": "STORY",
        "title": "PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook",
        "description": "",
        "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
        "pubDate": "2025-11-05T05:32:25Z",
        "displayTime": "2025-11-05T05:32:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PFE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o3tZoPUio75qXATbHoc_Hg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5rZqD7vIoFGnsFYAS_Ztw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 3:49 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 3:49 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 3:49 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 3:49 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T07:22:31+00:00",
    "headline": "Google Clears DOJ Antitrust Hurdle for $32 Billion Wiz Deal",
    "summary": "After the companies first announced their tie-up in March, the Justice Department opened up an in-depth probe of the deal, Bloomberg reported in June.  Wiz Chief Executive Officer Assaf Rappaport confirmed at a Wall Street Journal event on Tuesday that the DOJ concluded its review, but the deal is still under scrutiny by other antitrust regulators.  A Google spokesperson didn’t immediately respond outside regular business hours to a request for comment.",
    "url": "https://finance.yahoo.com/news/google-clears-doj-antitrust-hurdle-072231203.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "2ffa5cb0-f75e-30eb-a755-3afe3c1a2942",
      "content": {
        "id": "2ffa5cb0-f75e-30eb-a755-3afe3c1a2942",
        "contentType": "STORY",
        "title": "Google Clears DOJ Antitrust Hurdle for $32 Billion Wiz Deal",
        "description": "",
        "summary": "After the companies first announced their tie-up in March, the Justice Department opened up an in-depth probe of the deal, Bloomberg reported in June.  Wiz Chief Executive Officer Assaf Rappaport confirmed at a Wall Street Journal event on Tuesday that the DOJ concluded its review, but the deal is still under scrutiny by other antitrust regulators.  A Google spokesperson didn’t immediately respond outside regular business hours to a request for comment.",
        "pubDate": "2025-11-05T07:22:31Z",
        "displayTime": "2025-11-05T07:22:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/5a62293414e24b8304daf34d23631219",
          "originalWidth": 2000,
          "originalHeight": 1334,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4Nhvb_4r8kzx9IxUmdMHcw--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/5a62293414e24b8304daf34d23631219.cf.webp",
              "width": 2000,
              "height": 1334,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O3wDoCSB_ybxr60tJOVCWg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/5a62293414e24b8304daf34d23631219.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/google-clears-doj-antitrust-hurdle-072231203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/google-clears-doj-antitrust-hurdle-072231203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 4:22 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 4:22 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 4:22 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 4:22 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T10:15:00+00:00",
    "headline": "Here's Why Shares in Viking Therapeutics Shot Higher in October",
    "summary": "Three factors took Viking's shares higher in the month.",
    "url": "https://www.fool.com/investing/2025/11/05/heres-why-shares-in-viking-therapeutics-shot-highe/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "442465d0-d392-3e10-a36f-a08209cc7cc1",
      "content": {
        "id": "442465d0-d392-3e10-a36f-a08209cc7cc1",
        "contentType": "STORY",
        "title": "Here's Why Shares in Viking Therapeutics Shot Higher in October",
        "description": "",
        "summary": "Three factors took Viking's shares higher in the month.",
        "pubDate": "2025-11-05T10:15:00Z",
        "displayTime": "2025-11-05T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/89d7588798113f0fa43e6a4a04a23dbd",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A phone with Viking Therapeutics logo displayed on it.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wg8G7OI1eN8IuZ9mRf0sYg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/89d7588798113f0fa43e6a4a04a23dbd.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5KFo5nXB9HZLFelSAyLuOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/89d7588798113f0fa43e6a4a04a23dbd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/05/heres-why-shares-in-viking-therapeutics-shot-highe/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-shares-viking-therapeutics-101500376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T10:06:00+00:00",
    "headline": "Nucleic Acid Therapeutics Market Report 2025: Competition Intensifies as Pfizer, Sanofi, Novartis, Moderna, BioNTech Expand Antisense and RNA Platform Innovations - Long-term Forecast to 2029 & 2034",
    "summary": "The nucleic acid therapeutics market is growing due to rising genetic and chronic disease prevalence, expanding genomics R&D, and increased RNA therapeutics adoption. Key opportunities include precision medicine demand, mRNA applications, advanced delivery platforms, AI integration, and regulatory support. Nucleic Acid Therapeutics Market Nucleic Acid Therapeutics Market Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The \"Nucleic Acid Therapeutics Market Report 2025\" has been added to ResearchAndMark",
    "url": "https://finance.yahoo.com/news/nucleic-acid-therapeutics-market-report-100600971.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "fb9b3764-0558-360c-b239-070b4667145e",
      "content": {
        "id": "fb9b3764-0558-360c-b239-070b4667145e",
        "contentType": "STORY",
        "title": "Nucleic Acid Therapeutics Market Report 2025: Competition Intensifies as Pfizer, Sanofi, Novartis, Moderna, BioNTech Expand Antisense and RNA Platform Innovations - Long-term Forecast to 2029 & 2034",
        "description": "",
        "summary": "The nucleic acid therapeutics market is growing due to rising genetic and chronic disease prevalence, expanding genomics R&D, and increased RNA therapeutics adoption. Key opportunities include precision medicine demand, mRNA applications, advanced delivery platforms, AI integration, and regulatory support. Nucleic Acid Therapeutics Market Nucleic Acid Therapeutics Market Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The \"Nucleic Acid Therapeutics Market Report 2025\" has been added to ResearchAndMark",
        "pubDate": "2025-11-05T10:06:00Z",
        "displayTime": "2025-11-05T10:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d76177194e15f4fca5ad163bbf1a5a2b",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Nucleic Acid Therapeutics Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y_uzMvN4jpuzj0ey1IvG_A--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d76177194e15f4fca5ad163bbf1a5a2b.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rmC1iOZCaHctoRedXCRySg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d76177194e15f4fca5ad163bbf1a5a2b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nucleic-acid-therapeutics-market-report-100600971.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nucleic-acid-therapeutics-market-report-100600971.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "NOVN.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T10:00:00+00:00",
    "headline": "Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears.",
    "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.",
    "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
      "content": {
        "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears.",
        "description": "",
        "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.",
        "pubDate": "2025-11-05T10:00:00Z",
        "displayTime": "2025-11-05T10:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ba684ec8-e1fe-37a7-b161-5472c35e891e/novo-nordisk-stock-up-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xyHlGWIyozQ11qgbu0Gisw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N2uBceIjOWjhcBVcyJWYqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 5:43 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 5:43 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 5:43 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 5:43 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T13:19:26+00:00",
    "headline": "Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost",
    "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-amd-supermicro-and-novo-nordisk-stocks-fall-pinterest-tanks-while-lemonade-gets-a-boost-131926317.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "035a1404-14a9-4292-96b8-08cca27526ee",
      "content": {
        "id": "035a1404-14a9-4292-96b8-08cca27526ee",
        "contentType": "STORY",
        "title": "Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost",
        "description": "",
        "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
        "pubDate": "2025-11-05T13:19:26Z",
        "displayTime": "2025-11-05T13:19:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9",
          "originalWidth": 6580,
          "originalHeight": 4387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JWmy.F.Ma_VBhK_3OhXDhg--~B/aD00Mzg3O3c9NjU4MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9.cf.webp",
              "width": 6580,
              "height": 4387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/go.GUb6lR4YIVTlbTtCuOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-amd-supermicro-and-novo-nordisk-stocks-fall-pinterest-tanks-while-lemonade-gets-a-boost-131926317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-amd-supermicro-and-novo-nordisk-stocks-fall-pinterest-tanks-while-lemonade-gets-a-boost-131926317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "LMND"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "ARM"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "WEN"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "7203.T"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SNAP"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "XYZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T13:34:00+00:00",
    "headline": "CNS Summit releases annual Digital Innovation Index",
    "summary": "The CNS Summit Digital Innovation Index, created in partnership with IDEA Pharma, a division of SAI Med Partners, was unveiled during the CNS Summit annual meeting on November 4. The Index continues to assess and rank biopharma companies' progress in digital innovation across three key dimensions:",
    "url": "https://finance.yahoo.com/news/cns-summit-releases-annual-digital-133400025.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "610d83a6-2fc0-33fa-a71a-874e478a7340",
      "content": {
        "id": "610d83a6-2fc0-33fa-a71a-874e478a7340",
        "contentType": "STORY",
        "title": "CNS Summit releases annual Digital Innovation Index",
        "description": "",
        "summary": "The CNS Summit Digital Innovation Index, created in partnership with IDEA Pharma, a division of SAI Med Partners, was unveiled during the CNS Summit annual meeting on November 4. The Index continues to assess and rank biopharma companies' progress in digital innovation across three key dimensions:",
        "pubDate": "2025-11-05T13:34:00Z",
        "displayTime": "2025-11-05T13:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b9c966e031a43b97f763412e43e6cfcd",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_9J_M9YBIMwWrFGISfQfRg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b9c966e031a43b97f763412e43e6cfcd.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nq0wmE28KitrfU2Su9fLzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b9c966e031a43b97f763412e43e6cfcd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cns-summit-releases-annual-digital-133400025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cns-summit-releases-annual-digital-133400025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BAYN.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T13:06:00+00:00",
    "headline": "Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears.",
    "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.",
    "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
      "content": {
        "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears.",
        "description": "",
        "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.",
        "pubDate": "2025-11-05T13:06:00Z",
        "displayTime": "2025-11-05T13:06:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ba684ec8-e1fe-37a7-b161-5472c35e891e/novo-nordisk-stock-falls.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xyHlGWIyozQ11qgbu0Gisw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N2uBceIjOWjhcBVcyJWYqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T12:00:00+00:00",
    "headline": "Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update",
    "summary": "– Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease – – Presented preclinical data from ARV-806 demonstrating robust and differentiated activity in models of KRAS G12D-mutated cancer – – Presented preclinical data from ARV-027 demonstrating robust degradation of polyQ-AR in muscle, supporting further evaluation as a potentially disease-modifying therapy in SBMA – – Announced agreement with Pfizer to jointly select a thir",
    "url": "https://finance.yahoo.com/news/arvinas-reports-third-quarter-2025-120000941.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b4d752c2-222c-32e3-bce3-0c1addffe793",
      "content": {
        "id": "b4d752c2-222c-32e3-bce3-0c1addffe793",
        "contentType": "STORY",
        "title": "Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update",
        "description": "",
        "summary": "– Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease – – Presented preclinical data from ARV-806 demonstrating robust and differentiated activity in models of KRAS G12D-mutated cancer – – Presented preclinical data from ARV-027 demonstrating robust degradation of polyQ-AR in muscle, supporting further evaluation as a potentially disease-modifying therapy in SBMA – – Announced agreement with Pfizer to jointly select a thir",
        "pubDate": "2025-11-05T12:00:00Z",
        "displayTime": "2025-11-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081",
          "originalWidth": 696,
          "originalHeight": 252,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yh2mtJa2t7nTvrtnMIWuQQ--~B/aD0yNTI7dz02OTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081.cf.webp",
              "width": 696,
              "height": 252,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zGbLsZv8o._cDdc.ul0VDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arvinas-reports-third-quarter-2025-120000941.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arvinas-reports-third-quarter-2025-120000941.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ARVN"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T11:52:39+00:00",
    "headline": "Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats",
    "summary": "Both companies have upped their bids, but Novo Nordisk comes armed with an extra $1.9bn.",
    "url": "https://www.pharmaceutical-technology.com/news/novo-nordisk-and-pfizers-bidding-war-for-metsera-escalates-despite-legal-threats/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "276c8afb-049f-3877-a69c-4c895941f3a9",
      "content": {
        "id": "276c8afb-049f-3877-a69c-4c895941f3a9",
        "contentType": "STORY",
        "title": "Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats",
        "description": "",
        "summary": "Both companies have upped their bids, but Novo Nordisk comes armed with an extra $1.9bn.",
        "pubDate": "2025-11-05T11:52:39Z",
        "displayTime": "2025-11-05T11:52:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/d41e83f0b9ec9e75b7787a87f1385c2d",
          "originalWidth": 2560,
          "originalHeight": 1809,
          "caption": "Both Pfizer and Novo Nordisk are engaged in a bidding war for obesity biotech Metsera. Image credit: Sira Anamwong / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_TAxoZL4PJ2SQ1AfVhOXkA--~B/aD0xODA5O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/pharmaceutical_technology_376/d41e83f0b9ec9e75b7787a87f1385c2d.cf.webp",
              "width": 2560,
              "height": 1809,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZdElzEeqpRJtwq3Xcnbm3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/d41e83f0b9ec9e75b7787a87f1385c2d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/novo-nordisk-and-pfizers-bidding-war-for-metsera-escalates-despite-legal-threats/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-pfizer-bidding-war-115239909.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T11:48:00+00:00",
    "headline": "The AI Stocks Selloff Could Be a Bust or a Blip. This Will Decide Which.",
    "summary": "AMD beats expectations, Mamdani wins NYC mayoral election, Bitcoin briefly dips below $100,000, and more news to start your day.",
    "url": "https://www.barrons.com/articles/ai-stock-market-selloff-things-to-know-today-671cd5eb?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f33ef8a1-59f8-3f3b-8400-af9ab327661b",
      "content": {
        "id": "f33ef8a1-59f8-3f3b-8400-af9ab327661b",
        "contentType": "STORY",
        "title": "The AI Stocks Selloff Could Be a Bust or a Blip. This Will Decide Which.",
        "description": "",
        "summary": "AMD beats expectations, Mamdani wins NYC mayoral election, Bitcoin briefly dips below $100,000, and more news to start your day.",
        "pubDate": "2025-11-05T11:48:00Z",
        "displayTime": "2025-11-05T11:48:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f33ef8a1-59f8-3f3b-8400-af9ab327661b/the-ai-stocks-selloff-could.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8a7539560ffc9def390e86a91e577f8f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L3POLXpo17Oi.OjBZH3ZPA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8a7539560ffc9def390e86a91e577f8f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2WL1BdutbtwFKHVCeF.HqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8a7539560ffc9def390e86a91e577f8f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/ai-stock-market-selloff-things-to-know-today-671cd5eb?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "AMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T11:47:58+00:00",
    "headline": "Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise",
    "summary": "Competition and pricing weigh on the maker of Ozempic and Wegovy",
    "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-growth-outlook-114758156.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "62955298-c16c-31d3-8307-989b85e7ad7c",
      "content": {
        "id": "62955298-c16c-31d3-8307-989b85e7ad7c",
        "contentType": "STORY",
        "title": "Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise",
        "description": "",
        "summary": "Competition and pricing weigh on the maker of Ozempic and Wegovy",
        "pubDate": "2025-11-05T11:47:58Z",
        "displayTime": "2025-11-05T11:47:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9TzR39bxuUCR99sbuZJDMQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NjQrAqlrjUwsW.v1rUBg.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-growth-outlook-114758156.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-growth-outlook-114758156.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T11:38:40+00:00",
    "headline": "Metsera (MTSR) Climbs to New 52-Week High as Novo Ups Acquisition Bid to $10 Billion",
    "summary": "We recently published 10 Firms Stealing Market Spotlight Amid Bloodbath. Metsera, Inc. (NASDAQ:MTSR) is one of the best-performing stocks on Tuesday. Metsera rallied to a new all-time high on Tuesday after pharmaceutical giant Novo Nordisk heated up efforts to snatch the company from Pfizer Inc. for an upsized $10 billion acquisition offer. In intra-day trading, […]",
    "url": "https://finance.yahoo.com/news/metsera-mtsr-climbs-52-week-113840850.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ac805454-821c-385d-8dd9-82e39bca41f8",
      "content": {
        "id": "ac805454-821c-385d-8dd9-82e39bca41f8",
        "contentType": "STORY",
        "title": "Metsera (MTSR) Climbs to New 52-Week High as Novo Ups Acquisition Bid to $10 Billion",
        "description": "",
        "summary": "We recently published 10 Firms Stealing Market Spotlight Amid Bloodbath. Metsera, Inc. (NASDAQ:MTSR) is one of the best-performing stocks on Tuesday. Metsera rallied to a new all-time high on Tuesday after pharmaceutical giant Novo Nordisk heated up efforts to snatch the company from Pfizer Inc. for an upsized $10 billion acquisition offer. In intra-day trading, […]",
        "pubDate": "2025-11-05T11:38:40Z",
        "displayTime": "2025-11-05T11:38:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3",
          "originalWidth": 1000,
          "originalHeight": 681,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xFBTrAHbjCbg1tTtkCV2fg--~B/aD02ODE7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3.cf.webp",
              "width": 1000,
              "height": 681,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CBDWEfmuT6zO0KcotxAG5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-mtsr-climbs-52-week-113840850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-mtsr-climbs-52-week-113840850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 8:36 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 8:36 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 8:36 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 8:36 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 8:52 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 8:52 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 8:52 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 8:52 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 9:39 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 9:39 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 9:39 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 9:39 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T15:17:57+00:00",
    "headline": "Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled",
    "summary": "Novo Nordisk stock skidded early Wednesday after the Wegovy and Ozempic maker cut its sales outlook for the third time this year.",
    "url": "https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earnings-q3-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "5e3288da-97e6-3e00-9c9c-2cc71352bf07",
      "content": {
        "id": "5e3288da-97e6-3e00-9c9c-2cc71352bf07",
        "contentType": "STORY",
        "title": "Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled",
        "description": "",
        "summary": "Novo Nordisk stock skidded early Wednesday after the Wegovy and Ozempic maker cut its sales outlook for the third time this year.",
        "pubDate": "2025-11-05T15:17:57Z",
        "displayTime": "2025-11-05T15:17:57Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/5e3288da-97e6-3e00-9c9c-2cc71352bf07/novo-nordisk-cfo-on-metsera-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/696e305eae5fab01c4792ce7dd8ab971",
          "originalWidth": 1000,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/He_kFJUdWFn3UhcXC2FXOg--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/696e305eae5fab01c4792ce7dd8ab971.cf.webp",
              "width": 1000,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nAFgy7JpnMt7c2Nsbyqk9w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/696e305eae5fab01c4792ce7dd8ab971.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earnings-q3-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 10:10 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 10:10 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 10:10 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 10:10 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 10:56 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 10:56 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 10:56 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 10:56 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T15:43:00+00:00",
    "headline": "Ozempic Maker Novo Nordisk Lowers Growth Outlook",
    "summary": "Intensifying competition, pricing pressure and copycat versions of its weight-loss drugs are holding back sales at the pharma giant.",
    "url": "https://www.wsj.com/health/pharma/ozempic-maker-novo-nordisk-lowers-growth-outlook-of-its-blockbuster-drugs-013a0df1?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cb7698fc-a17d-3e68-b826-12df68136b63",
      "content": {
        "id": "cb7698fc-a17d-3e68-b826-12df68136b63",
        "contentType": "STORY",
        "title": "Ozempic Maker Novo Nordisk Lowers Growth Outlook",
        "description": "",
        "summary": "Intensifying competition, pricing pressure and copycat versions of its weight-loss drugs are holding back sales at the pharma giant.",
        "pubDate": "2025-11-05T15:43:00Z",
        "displayTime": "2025-11-05T15:43:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cb7698fc-a17d-3e68-b826-12df68136b63/ozempic-maker-novo-nordisk.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/48a709135c2bb8041e1bfe820aa5b6fd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KUrJN2tH8LWa0.dI.mqm8A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/48a709135c2bb8041e1bfe820aa5b6fd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OuKvvpttr7cWKxzMQGJ5yA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/48a709135c2bb8041e1bfe820aa5b6fd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/ozempic-maker-novo-nordisk-lowers-growth-outlook-of-its-blockbuster-drugs-013a0df1?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 11:45 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 11:45 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 11:45 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 11:45 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 12:34 p.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 12:34 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 12:34 p.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 12:34 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T19:02:20+00:00",
    "headline": "Arvinas Inc (ARVN) Q3 2025 Earnings Call Highlights: Clinical Advancements and Strategic ...",
    "summary": "Arvinas Inc (ARVN) showcases promising clinical progress and strategic partnerships, despite facing revenue declines and operational downsizing.",
    "url": "https://finance.yahoo.com/news/arvinas-inc-arvn-q3-2025-190220446.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "8ff2a7f3-e931-3dfc-abfa-3c6be416d11b",
      "content": {
        "id": "8ff2a7f3-e931-3dfc-abfa-3c6be416d11b",
        "contentType": "STORY",
        "title": "Arvinas Inc (ARVN) Q3 2025 Earnings Call Highlights: Clinical Advancements and Strategic ...",
        "description": "",
        "summary": "Arvinas Inc (ARVN) showcases promising clinical progress and strategic partnerships, despite facing revenue declines and operational downsizing.",
        "pubDate": "2025-11-05T19:02:20Z",
        "displayTime": "2025-11-05T19:02:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/c1ef89a95729e053da2946f0d4aa965a",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lx1AUoskjKn9fBJMokQVyg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/c1ef89a95729e053da2946f0d4aa965a.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a4yVm_X8j9zS64cTxeoxDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/c1ef89a95729e053da2946f0d4aa965a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arvinas-inc-arvn-q3-2025-190220446.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arvinas-inc-arvn-q3-2025-190220446.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ARVN"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 2:32 p.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 2:32 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 2:32 p.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 2:32 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 3:03 p.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 3:03 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 3:03 p.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 3:03 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 4:03 p.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 4:03 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 4:03 p.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 4:03 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T21:33:29+00:00",
    "headline": "Earnings live: Snap stock soars, DoorDash and Duolingo plunge in post-earnings swoon",
    "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-snap-stock-soars-doordash-and-duolingo-plunge-in-post-earnings-swoon-213329634.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "035a1404-14a9-4292-96b8-08cca27526ee",
      "content": {
        "id": "035a1404-14a9-4292-96b8-08cca27526ee",
        "contentType": "STORY",
        "title": "Earnings live: Snap stock soars, DoorDash and Duolingo plunge in post-earnings swoon",
        "description": "",
        "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
        "pubDate": "2025-11-05T21:33:29Z",
        "displayTime": "2025-11-05T22:24:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/0a165210-ba8f-11f0-bfe9-b7383d1ac623",
          "originalWidth": 3500,
          "originalHeight": 2333,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CjNxKHiKwI2tPrS0e92p3g--~B/aD0yMzMzO3c9MzUwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/0a165210-ba8f-11f0-bfe9-b7383d1ac623.cf.webp",
              "width": 3500,
              "height": 2333,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/31h1pT.5BXMqGWxJ8hUaSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/0a165210-ba8f-11f0-bfe9-b7383d1ac623.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-snap-stock-soars-doordash-and-duolingo-plunge-in-post-earnings-swoon-213329634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-snap-stock-soars-doordash-and-duolingo-plunge-in-post-earnings-swoon-213329634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SNAP"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "WEN"
            },
            {
              "symbol": "DUOL"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "ARM"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "7203.T"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "XYZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T22:08:00+00:00",
    "headline": "Pfizer Responds to Delaware Chancery Court Ruling",
    "summary": "NEW YORK, November 05, 2025--Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, Inc. from terminating the existing merger agreement in favor of a competing proposal from Novo Nordisk.",
    "url": "https://finance.yahoo.com/news/pfizer-responds-delaware-chancery-court-220800308.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ca4f1b60-8fcb-3521-b557-9c011489e9f3",
      "content": {
        "id": "ca4f1b60-8fcb-3521-b557-9c011489e9f3",
        "contentType": "STORY",
        "title": "Pfizer Responds to Delaware Chancery Court Ruling",
        "description": "",
        "summary": "NEW YORK, November 05, 2025--Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, Inc. from terminating the existing merger agreement in favor of a competing proposal from Novo Nordisk.",
        "pubDate": "2025-11-05T22:08:00Z",
        "displayTime": "2025-11-05T22:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2428824719b7f4a38bce766b47a09472",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7YLU.G0nM9qe_iXUjUOdpg--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2428824719b7f4a38bce766b47a09472.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SYGV3A279hl_X7XlJmZiCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2428824719b7f4a38bce766b47a09472.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-responds-delaware-chancery-court-220800308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-responds-delaware-chancery-court-220800308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T21:15:00+00:00",
    "headline": "Moderna Is Running Low on Cash. Its Earnings Are Thursday.",
    "summary": "Moderna  reports earnings early Thursday as investors wonder whether the biotech will run through its pandemic-era windfall before it stops losing money.  The vaccine company had accumulated nearly $20 billion in cash by early 2022, thanks to the record-smashing sales of its Covid-19 shot, but has been losing billions of dollars a year since 2023.  Management has said Moderna will have $6 billion left at the end of this year, will stop losing money in 2028, and won’t need to raise any new cash to bridge the gap.",
    "url": "https://www.barrons.com/articles/moderna-stock-earnings-preview-51975438?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "0b5bfd14-9904-3099-a0a9-8b9596ae958e",
      "content": {
        "id": "0b5bfd14-9904-3099-a0a9-8b9596ae958e",
        "contentType": "STORY",
        "title": "Moderna Is Running Low on Cash. Its Earnings Are Thursday.",
        "description": "",
        "summary": "Moderna  reports earnings early Thursday as investors wonder whether the biotech will run through its pandemic-era windfall before it stops losing money.  The vaccine company had accumulated nearly $20 billion in cash by early 2022, thanks to the record-smashing sales of its Covid-19 shot, but has been losing billions of dollars a year since 2023.  Management has said Moderna will have $6 billion left at the end of this year, will stop losing money in 2028, and won’t need to raise any new cash to bridge the gap.",
        "pubDate": "2025-11-05T21:15:00Z",
        "displayTime": "2025-11-05T21:15:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0b5bfd14-9904-3099-a0a9-8b9596ae958e/moderna-is-running-low-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e36505993ad3703ab9de7fbae2fb93fe",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/749fjdDNHOZZaiWMxvk7TQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e36505993ad3703ab9de7fbae2fb93fe.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rrBpMbNzvxDHGSjZc1Bgxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e36505993ad3703ab9de7fbae2fb93fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/moderna-stock-earnings-preview-51975438?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T11:30:00+00:00",
    "headline": "Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera",
    "summary": "Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer's bid of $8 billion.",
    "url": "https://www.thedailyupside.com/industries/healthcare/novo-nordisk-offers-10-billion-for-obesity-biotech-metsera/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "bfc5f1dc-7647-3dfb-852b-dac5c486f4b9",
      "content": {
        "id": "bfc5f1dc-7647-3dfb-852b-dac5c486f4b9",
        "contentType": "STORY",
        "title": "Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera",
        "description": "",
        "summary": "Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer's bid of $8 billion.",
        "pubDate": "2025-11-05T11:30:00Z",
        "displayTime": "2025-11-05T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/3d0e452cdfc4c1b7859fc4b224d6cdcd",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Photo of a Novo Nordisk office building.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OjTS4qMBK50XZ0eqzWYF6A--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/3d0e452cdfc4c1b7859fc4b224d6cdcd.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rBeaRFPU9cdgS8i_QVES_A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/3d0e452cdfc4c1b7859fc4b224d6cdcd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/novo-nordisk-offers-10-billion-for-obesity-biotech-metsera/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-10-billion-bid-113000817.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "HELE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 5:31 p.m. EST",
    "summary": "The Federal Aviation Administration announced Wednesday that it will reduce air traffic by 10% across 40 “high-volume” markets beginning Friday morning to maintain safety during the ongoing government shutdown",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 5:31 p.m. EST",
        "description": "",
        "summary": "The Federal Aviation Administration announced Wednesday that it will reduce air traffic by 10% across 40 “high-volume” markets beginning Friday morning to maintain safety during the ongoing government shutdown",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]